Skip to Main Content

Advertisement

Skip Nav Destination

Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma

Cancer Res (2023) 83 (14): 2405–2420.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Chuan Long
  • Han Peng
  • Wei Yang
  • Min Wang
  • Bo Luo
  • Jie Hao
  • Yan Dong
  • Wenwei Zuo
ACS Omega (2024) 9 (10): 11998.
  • Yanhua Dai
  • Zhongjian Ji
  • Hongyan Liang
  • Meng Jiang
  • Lan Wang
  • Xinyi Bao
  • Jiaren Liu
  • Ming Liu
  • Chun Yang
Cancer Science (2024)
  • Dino Bekric
  • Tobias Kiesslich
  • Matthias Ocker
  • Martina Winklmayr
  • Markus Ritter
  • Heidemarie Dobias
  • Marlena Beyreis
  • Daniel Neureiter
  • Christian Mayr
  • Hiroyasu Nakano
PLOS ONE (2024) 19 (4): e0302050.
Close Modal

or Create an Account

Close Modal
Close Modal